Sangamo Therapeutics Inc (NASDAQ:SGMO)

24.95
Delayed Data
As of Feb 23
 -0.45 / -1.77%
Today’s Change
3.65
Today|||52-Week Range
27.50
+52.13%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Operating ActivitiesNet Income / Starting Line-16.6M-12.5M-12.4M--
 
 
 
 
Depreciation301.0K317.0K412.0K--
 
 
 
 
Total Other Cash Flow2.9M1.9M1.8M--
 
 
 
 
Funds From Operations-13.4M-10.3M-10.1M--
 
 
 
 
Funds From/For Other Operating Expenses-333.0K-67.1M5.6M--
 
 
 
 
Net Cash Flow - Operating Activities-13.1M56.8M-15.7M--
 
 
 
 
 
InvestingIncrease In Investments-39.0M-120.2M-70.4M--
 
 
 
 
Decrease In Investments45.5M37.5M44.1M--
 
 
 
 
Capital Expenditures-468.0K-1.7M-698.0K--
 
 
 
 
Net Cash Flow Investing6.1M-84.4M-27.1M--
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.00----
Long Term Borrowings----------
Long Term Debt Reduction----------
Net Proceeds Stock Sale3.4M78.9M2.8M--
 
 
 
 
Common Preferred Redeemed0.000.000.00----
Common Dividends----------
Cash Dividends Paid - Total0.000.000.00----
Other Sources - Financing----------
Other Uses - Financing4.0K3.0K-7.0K--
 
 
 
 
Net Cash Flow - Financing3.4M78.9M2.8M--
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash----------
 
Net Change In Cash-3.6M51.4M-39.9M0.00